Quarterly report pursuant to Section 13 or 15(d)

License Agreements (Journey and Other Narrative) (Details)

v3.24.3
License Agreements (Journey and Other Narrative) (Details) - USD ($)
$ in Thousands
 1 Months Ended 3 Months Ended 9 Months Ended
Nov. 04, 2024
Jun. 30, 2021
Sep. 30, 2023
Sep. 30, 2023
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Other revenue     $ 19,260 $ 19,519
Journey | Licensing Agreements | Dr. Reddy's Laboratories, Ltd | DFD Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Upfront fees payment   $ 10,000    
Asset purchase agreement, percentage of royalties   20.00%    
Journey | Licensing Agreements | Dr. Reddy's Laboratories, Ltd | Subsequent events | DFD Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Payments of milestones $ 15,000      
Journey | Licensing Agreements | Dr. Reddy's Laboratories, Ltd | Achievement of Certain Clinical Development, Regulatory and First Commercial Sale milestones | DFD Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Payments of milestones   $ 140,000    
Journey | Licensing Agreements | Minimum | Dr. Reddy's Laboratories, Ltd | DFD Agreement        
Research and Development Arrangement, Contract to Perform for Others [Line Items]        
Asset purchase agreement, percentage of royalties   10.00%